Start Your Risk-Free Trial

Olopatadine — Discount Pricing

Olopatadine is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.

Olopatadine Pricing

Pricing typePrice
TheDrugClubDiscount pricing may be available
Typical Retail$41.00

Discount pricing may be available; confirm the price with the dispensing pharmacy.

About Olopatadine

Olopatadine is a prescription medication. Ask your doctor if Olopatadine is right for you.

Other strengths and forms of Olopatadine

Conditions Treated with Olopatadine

How to Check Olopatadine Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available discount pricing

Olopatadine at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Allergic Conjunctivitis

Other medications in Eye & Vision

What Olopatadine is approved for (FDA label)

Olopatadine hydrochloride nasal spray is indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 years of age and older. Olopatadine hydrochloride nasal spray is an H 1 receptor antagonist indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 years of age and older ( 1 ).

Source: Read the full FDA label on DailyMed. Label effective date: August 15, 2024.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Olopatadine (FDA label)

Nasal spray: 665 mcg olopatadine hydrochloride per spray supplied in a white plastic bottle with a metered-dose manual spray pump, a white nasal applicator, a blue overcap and a blue clip. Nasal spray: 665 mcg of olopatadine hydrochloride in each spray ( 3 ).

Source: FDA prescribing information (DailyMed). Set ID: db024b9c-681f-4503-9fda-1eaa1add4746. SPL document ID: 1f877375-4665-4f9b-92af-93c6d73e2313. Label effective date: August 15, 2024. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Olopatadine (FDA label)

The most clinically significant adverse reactions described in other sections of labeling include: • Epistaxis, Nasal Ulceration, and Nasal Septal Perforation [ see Warnings and Precautions ( 5.1 ) ] • Somnolence and Impaired Mental Alertness [ see Warnings and Precautions ( 5.2 ) ] The most common (>1%) adverse reactions, included bitter taste, headache, epistaxis, pharyngolaryngeal pain, post-nasal drip, cough, and urinary tract infection in patients 12 years of age and older and epistaxis, headache, upper respiratory tract infection, bitter taste, pyrexia, and rash in patients 6 to 11 years of age ( 6.1 ).

Source: FDA prescribing information (DailyMed). Set ID: db024b9c-681f-4503-9fda-1eaa1add4746. SPL document ID: 1f877375-4665-4f9b-92af-93c6d73e2313. Label effective date: August 15, 2024. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Olopatadine (FDA label)

None. None ( 4 ).

Source: FDA prescribing information (DailyMed). Set ID: db024b9c-681f-4503-9fda-1eaa1add4746. SPL document ID: 1f877375-4665-4f9b-92af-93c6d73e2313. Label effective date: August 15, 2024. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial